Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer

Por Simms, M S, Scholfield, D P, Jacobs, E, Michaeli, D, Broome, P, Humphreys, J E, Bishop, M C
Publicado em 2000

Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER

Por Kaplan, S A, Cardozo, L, Herschorn, S, Grenabo, L, Carlsson, M, Arumi, D, Crook, T J, Whelan, L, Scholfield, D, Ntanios, F
Publicado no Int J Clin Pract (2014)